These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 35913830)

  • 1. Case-Matched Comparison of Functional and Quality of Life Outcomes of Local Excision and Total Mesorectal Excision Following Chemoradiotherapy for Rectal Cancer.
    Brachet S; Meillat H; Chanez B; Ratone JP; Brunelle S; Tyran M; Poizat F; de Chaisemartin C; Lelong B
    Dis Colon Rectum; 2022 Dec; 65(12):1464-1474. PubMed ID: 35913830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Anterior Resection Syndrome After Transanal Total Mesorectal Excision: A Comparison With the Conventional Top-to-Bottom Approach.
    Foo CC; Kin Ng K; Tsang JS; Siu-Hung Lo O; Wei R; Yip J; Lun Law W
    Dis Colon Rectum; 2020 Apr; 63(4):497-503. PubMed ID: 32015290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Outcomes and Quality of Life After Transanal Total Mesorectal Excision for Rectal Cancer: A Prospective Observational Study.
    de Lacy FB; Turrado-Rodriguez V; Torroella A; van Laarhoven J; Otero-PiƱeiro A; Almenara R; Lacima G; Castells A; Lacy AM
    Dis Colon Rectum; 2022 Jan; 65(1):46-54. PubMed ID: 34596984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
    Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
    Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of Patients With Local Regrowth After Nonoperative Management of Rectal Cancer After Neoadjuvant Chemoradiotherapy.
    Cotti GC; Pandini RV; Braghiroli OFM; Nahas CSR; Bustamante-Lopez LA; Marques CFS; Imperiale AR; Ribeiro U; Salvajoli B; Hoff PM; Nahas SC
    Dis Colon Rectum; 2022 Mar; 65(3):333-339. PubMed ID: 34775415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of Life and Functional Outcomes After Intersphincteric Resection for Ultralow Rectal Cancer: A Prospective Observational Study.
    Zhang B; Zhuo GZ; Zhao Y; Zhao YJ; Zhu J; Liu FF; Ding JH
    Dis Colon Rectum; 2023 Jul; 66(7):1029-1038. PubMed ID: 36602458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed TME Surgery in a Watch-and-Wait Strategy After Neoadjuvant Chemoradiotherapy for Rectal Cancer: An Analysis of Hospital Costs and Surgical and Oncological Outcomes.
    Meyer VM; Meuzelaar RR; Schoenaker IJH; de Groot JB; Reerink O; de Vos Tot Nederveen Cappel WH; Beets GL; van Westreenen HL
    Dis Colon Rectum; 2023 May; 66(5):671-680. PubMed ID: 34856587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transanal Total Mesorectal Excision in Mid-Low Rectal Cancer: Evaluation of the Learning Curve and Comparison of Short-term Results With Standard Laparoscopic Total Mesorectal Excision.
    Zeng Z; Liu Z; Huang L; Liu H; Jie H; Luo S; Zhang X; Kang L
    Dis Colon Rectum; 2021 Apr; 64(4):380-388. PubMed ID: 33394779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in ypT0-1 Rectal Cancer After Preoperative Radiochemotherapy: Postoperative Morbidity, Functional Results, and Long-term Oncologic Outcome.
    Rizzo G; Pafundi DP; Sionne F; Pietricola G; D'Agostino L; Gambacorta MA; Valentini V; Coco C
    Dis Colon Rectum; 2022 Nov; 65(11):1306-1315. PubMed ID: 35067503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does Completeness of the Mesorectal Excision Still Correlate With Local Recurrence?
    Garoufalia Z; Freund MR; Gefen R; Meyer R; DaSilva G; Weiss EG; Wexner SD
    Dis Colon Rectum; 2023 Jul; 66(7):898-904. PubMed ID: 36649177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Total Neoadjuvant Therapy on Postoperative Outcomes After Proctectomy for Rectal Cancer.
    Xu Z; Valente MA; Sklow B; Liska D; Gorgun E; Kessler H; Rosen DR; Steele SR
    Dis Colon Rectum; 2023 Jul; 66(7):1022-1028. PubMed ID: 36538720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
    Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
    Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in Surgical Outcomes and Quality-of-Life Outcomes in Pelvic Exenteration Between Locally Advanced Versus Locally Recurrent Rectal Cancers.
    Huang Y; Steffens D; Koh CE; Young JM; Solomon MJ
    Dis Colon Rectum; 2022 Dec; 65(12):1475-1482. PubMed ID: 35913831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
    Zhang J; Li J; Huang M; Xie X; Cai Y; Hu H; Ling J; Wu Z; Deng Y
    Dis Colon Rectum; 2023 Jul; 66(7):934-945. PubMed ID: 35834598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Experience With Transanal Total Mesorectal Excision Compared With Laparoscopic Total Mesorectal Excision for Rectal Cancer: A Propensity Score-Matched Analysis.
    Alhanafy MK; Park SS; Park SC; Park B; Kim MJ; Sohn DK; Chang HJ; Oh JH
    Dis Colon Rectum; 2020 Nov; 63(11):1500-1510. PubMed ID: 33044291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anterior Resection Syndrome and Quality of Life With Long-term Follow-up After Rectal Cancer Resection.
    Dilke SM; Hadjittofi C; Than M; Tozer PJ; Stearns AT;
    Dis Colon Rectum; 2022 Oct; 65(10):1251-1263. PubMed ID: 34840295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Outcomes and Quality of Life after Redo Anastomosis in Patients With Rectal Cancer: An International Multicenter Comparative Cohort Study.
    Westerduin E; Elfeki H; Frontali A; Lakkis Z; Laurberg S; Tanis PJ; Wolthuis AM; Panis Y; D'Hoore A; Bemelman WA; Juul T
    Dis Colon Rectum; 2021 Jul; 64(7):822-832. PubMed ID: 33902088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncologic Outcomes After Transanal Total Mesorectal Excision for Rectal Cancer.
    Maykel JA; Hahn SJ; Beauharnais CC; Meyer DC; Hill SS; Sturrock PR; Davids JS; Alavi K
    Dis Colon Rectum; 2022 Jun; 65(6):827-836. PubMed ID: 34629431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robot-Assisted Total Mesorectal Excision Versus Laparoscopic Total Mesorectal Excision: A Retrospective Propensity Score-Matched Cohort Analysis in Experienced Centers.
    Burghgraef TA; Crolla RMPH; Verheijen PM; Fahim M; van Geloven A; Leijtens JWA; Pronk A; Smits AB; Verdaasdonk EGG; Consten ECJ
    Dis Colon Rectum; 2022 Feb; 65(2):218-227. PubMed ID: 34459449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robot Surgery Shows Similar Long-term Oncologic Outcomes as Laparoscopic Surgery for Mid/Lower Rectal Cancer but Is Beneficial to ypT3/4 After Preoperative Chemoradiation.
    Park SY; Lee SM; Park JS; Kim HJ; Choi GS
    Dis Colon Rectum; 2021 Jul; 64(7):812-821. PubMed ID: 33833141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.